Skip to content

Clinical trials

Glomerulosclerosis, Focal Segmental trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20183
20202
20212
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Travere Therapeutics, Inc.3
Amgen1
Boehringer Ingelheim1
Dimerix Bioscience Pty Ltd1
Genzyme, a Sanofi Company1
Novartis Pharmaceuticals1
Pfizer1
River 3 Renal Corp.1
Sanofi1
UK Kidney Association1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental13
Glomerulonephritis, IGA4
Nephritis, Hereditary4
Nephrosis, Lipoid3
Kidney Diseases2
Atypical Hemolytic Uremic Syndrome1
Bartter Syndrome1
Calciphylaxis1
Cystinosis1
Cystinuria1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.